Amgen (AMGN) Current Assets (2009 - 2026)

Amgen's Current Assets history runs 18 years deep, the most recent figure standing at $31.5 billion for Q1 2026.

• In Q1 2026, Current Assets rose 16.88% year-over-year to $31.5 billion; the TTM figure through Mar 2026 stood at $31.5 billion (up 16.88% YoY), while the FY2025 annual figure was $29.1 billion, changed 0.09% from the prior year.
• Current Assets was $31.5 billion for Q1 2026 at Amgen, up from $29.1 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $48.5 billion in Q3 2023 to a low of $18.5 billion in Q1 2022.
• Historically, Current Assets has averaged $29.9 billion across 5 years, with a median of $27.9 billion in 2025.
• The sharpest annual moves came in 2023 and 2024: Current Assets surged 145.21% in 2023, then slumped 44.79% in 2024.
• A 5-year view of Current Assets shows it stood at $22.2 billion in 2022, then soared by 36.72% to $30.3 billion in 2023, then slipped by 4.29% to $29.0 billion in 2024, then increased by 0.09% to $29.1 billion in 2025, then advanced by 8.32% to $31.5 billion in 2026.
• The last three Current Assets figures came in at $31.5 billion (Q1 2026), $29.1 billion (Q4 2025), and $27.9 billion (Q3 2025), per Business Quant data.